The epidemiology of haemodialysis catheter infections in Australia, 2016–20: a prospective cohort study
Benjamin Lazarus(University of Vienna), Sradha Kotwal(The George Institute for Global Health), Martin Gallagher(The George Institute for Global Health), Sarah Coggan(UNSW Sydney), Jayson Catiwa(Prince of Wales Hospital), Stephen P. McDonald(Royal Adelaide Hospital), Kevan R. Polkinghorne(Monash Health), Nicholas A. Gray(Sunshine Coast University Hospital), Girish Talaulikar(Australian National University), K Higgins(George Institute for Global Health)
Cited by 3
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
|JAMA Internal Medicine|2016|725
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|620